Gene · 5949
RBP3: retinol binding protein 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RBP3: retinol binding protein 3. Genes, record 5949. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5949
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P10745 | Retinol-binding protein 3 | 1,247 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents63
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026515744 A | 2026-05-19 | 174 | P10745 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 61577 | P10745 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 17483 | P10745 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 11254 | P10745 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7531 | P10745 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7531 | P10745 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 17483 | P10745 | Espacenet |
| JP 2025508740 A | 2025-04-10 | 152 | P10745 | Espacenet |
| JP 2025028927 A | 2025-03-05 | 180 | P10745 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 11254 | P10745 | Espacenet |
1 to 10 of 63
See all 63 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants729
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RBP3 papers | Newest fiscal year |
|---|---|---|---|
| ZIAEY000184 | Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina | 25 | 2025 |
| P30EY006360 | P30-Core Grant for Vision Research | 12 | 2025 |
| P30EY014800 | University of Utah Core Vision Research Grant | 11 | 2025 |
| P30EY010572 | Ophthalmology Core Facility | 10 | 2025 |
| P30EY011373 | CWRU NEI Vision Center Core Grant | 8 | 2025 |
| R01EY010609 | Mechanism of photoreceptor cell degeneration in animal models of retinal diseases | 8 | 2025 |
| P30EY000331 | Vision Research Core at UCLA | 7 | 2025 |
| P30EY001792 | P30 Core Grant for Vision Research | 7 | 2025 |
| R01EY009339 | Retinoids in Vision | 7 | 2025 |
| R01EY011600 | Biochemistry and Pharmacology of the Macular Carotenoids | 7 | 2025 |
1 to 10 of 729Source NIH's project files
See all 729 nih grantsPapers1,286
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retinol-binding protein 3 in ophthalmology: current evidence, research progress, and future perspectives. | Front Immunol | 2026 | 42516372 | PubTator, text mining | PubMed |
| LAG3 Gene Therapy Attenuates Autoimmune Uveitis by Regulating the PI3K/Akt Signaling Pathway. | Invest Ophthalmol Vis Sci | 2026 | 42484593 | PubTator, text mining | PubMed |
| Streamlined synthetic regulatory cassette for efficient and photoreceptor-enriched retinal gene expression. | Mol Ther Nucleic Acids | 2026 | 42367246 | PubTator, text mining | PubMed |
| Digital PCR Quantification of a Circulating RBP3 and CRX RNA Signature Establishes a Liquid Biopsy Framework for Precision Monitoring of Retinoblastoma. | Int J Mol Sci | 2026 | 42196162 | PubTator, text mining | PubMed |
| The Immunopathogenesis of uveitis. | Front Med (Lausanne) | 2026 | 41877771 | PubTator, text mining | PubMed |
| Detection of Leishmania infantum DNA in captive wild mammals from an urban zoo in a visceral leishmaniasis-endemic area of Brazil. | PLoS Negl Trop Dis | 2026 | 41860882 | PubTator, text mining | PubMed |
| Bumetanide‑blocked SLC12A2 exerts a protective effect in experimental diabetic retinopathy. | Int J Mol Med | 2026 | 41789623 | PubTator, text mining | PubMed |
| Clinical and Molecular Characteristics of Foveal Sparing Phenotype in Chinese Patients With Inherited Retinal Diseases. | Transl Vis Sci Technol | 2026 | 41700794 | PubTator, text mining | PubMed |
| Balitora tiandengensis (Teleostei, Balitoridae), a new species of cave-dwelling loach from Guangxi, China. | Zookeys | 2026 | 41659379 | PubTator, text mining | PubMed |
| Altered B cell activation contributes to the immunopathogenesis of childhood arthritis-associated uveitis. | Nat Commun | 2026 | 41633998 | PubTator, text mining | PubMed |
1 to 10 of 1,286
See all 1,286 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/5949
GET https://conductscience.org/api/genes/v1/5949/patents?page=2